Journal articles on the topic 'Cancer molecular targets'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Cancer molecular targets.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Weigelt, Britta, and Susana Banerjee. "Molecular targets and targeted therapeutics in endometrial cancer." Current Opinion in Oncology 24, no. 5 (September 2012): 554–63. http://dx.doi.org/10.1097/cco.0b013e328354e585.
Full textKummar, Shivaani, and James H. Doroshow. "Molecular targets in cancer therapy." Expert Review of Anticancer Therapy 13, no. 3 (March 2013): 267–69. http://dx.doi.org/10.1586/era.12.170.
Full textLorch, Jochen H. "Molecular Targets for Thyroid Cancer." Oncology Times 35 (June 2013): 2–3. http://dx.doi.org/10.1097/01.cot.0000431825.52663.3e.
Full textLazo, John S., and Elizabeth R. Sharlow. "Drugging Undruggable Molecular Cancer Targets." Annual Review of Pharmacology and Toxicology 56, no. 1 (January 6, 2016): 23–40. http://dx.doi.org/10.1146/annurev-pharmtox-010715-103440.
Full textGale, Danielle M. "Molecular targets in cancer therapy." Seminars in Oncology Nursing 19, no. 3 (August 2003): 193–205. http://dx.doi.org/10.1016/s0749-2081(03)00047-0.
Full textWestwell, Andrew D. "Molecular targets and cancer therapeutics." Drug Discovery Today 9, no. 24 (December 2004): 1042–44. http://dx.doi.org/10.1016/s1359-6446(04)03287-8.
Full textWilliam, William N., John V. Heymach, Edward S. Kim, and Scott M. Lippman. "Molecular targets for cancer chemoprevention." Nature Reviews Drug Discovery 8, no. 3 (March 2009): 213–25. http://dx.doi.org/10.1038/nrd2663.
Full textZaenker, K. S., G. Mustacchi, and E. Mihich. "Molecular targets of cancer chemotherapy." Cancer Chemotherapy and Pharmacology 58, no. 2 (December 24, 2005): 279–82. http://dx.doi.org/10.1007/s00280-005-0170-9.
Full textRossig, Claudia. "Immune modulation by molecular cancer targets and targeted therapies." OncoImmunology 1, no. 3 (May 2012): 358–60. http://dx.doi.org/10.4161/onci.18401.
Full textWang, Shihao, Jinqiu Shen, Boyang Zhang, Jiao Tian, Wei Zhao, and Wenzheng Wu. "Molecular mechanism study of cancer treatment based on network pharmacology of lily." Highlights in Science, Engineering and Technology 14 (September 29, 2022): 397–403. http://dx.doi.org/10.54097/hset.v14i.1852.
Full textHoriguchi, Yutaka. "Current Molecular Targets for Urological Cancer." Forum on Immunopathological Diseases and Therapeutics 4, no. 1 (2013): 25–32. http://dx.doi.org/10.1615/forumimmundisther.2013008313.
Full textNAKANO, Shuji. "New Molecular Targets for Cancer Chemotherapy." Internal Medicine 38, no. 2 (1999): 186–90. http://dx.doi.org/10.2169/internalmedicine.38.186.
Full textEastman, Peggy. "Molecular Targets & Innovative Cancer Therapeutics." Oncology Times 39, no. 1 (January 2017): 34–35. http://dx.doi.org/10.1097/01.cot.0000512069.74279.a1.
Full textZacharakis, Evangelos, Mahmoud Monem, Jean V. Joseph, and Hiten RH Patel. "Molecular therapeutic targets for bladder cancer." Expert Review of Anticancer Therapy 7, no. 12 (December 2007): 1691–93. http://dx.doi.org/10.1586/14737140.7.12.1691.
Full textRomero, Diana. "From Molecular Targets and Cancer Therapeutics." Nature Reviews Clinical Oncology 17, no. 1 (November 13, 2019): 6. http://dx.doi.org/10.1038/s41571-019-0302-5.
Full textHuntsman, D. "Emerging Molecular Targets in Gynaecological Cancer." Annals of Oncology 25 (September 2014): iv18. http://dx.doi.org/10.1093/annonc/mdu300.1.
Full textOliff, Allen, Jackson B. Gibbs, and Frank McCormick. "New Molecular Targets for Cancer Therapy." Scientific American 275, no. 3 (September 1996): 144–49. http://dx.doi.org/10.1038/scientificamerican0996-144.
Full textBlagden, Sarah, and Hani Gabra. "Promising molecular targets in ovarian cancer." Current Opinion in Oncology 21, no. 5 (September 2009): 412–19. http://dx.doi.org/10.1097/cco.0b013e32832eab1f.
Full textTuorkey, Muobarak J. "Molecular targets of luteolin in cancer." European Journal of Cancer Prevention 25, no. 1 (January 2016): 65–76. http://dx.doi.org/10.1097/cej.0000000000000128.
Full textWolff, Robert A. "Exploiting molecular targets in pancreatic cancer." Hematology/Oncology Clinics of North America 16, no. 1 (February 2002): 139–57. http://dx.doi.org/10.1016/s0889-8588(01)00012-0.
Full textFaria, J., G. Negalha, A. Azevedo, and F. Martel. "Metformin and Breast Cancer: Molecular Targets." Journal of Mammary Gland Biology and Neoplasia 24, no. 2 (March 22, 2019): 111–23. http://dx.doi.org/10.1007/s10911-019-09429-z.
Full textTucker, Gordon C. "Integrins: Molecular targets in cancer therapy." Current Oncology Reports 8, no. 2 (April 2006): 96–103. http://dx.doi.org/10.1007/s11912-006-0043-3.
Full textSivaganesh, Vignesh, Nazifa Promi, Salma Maher, and Bela Peethambaran. "Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer." International Journal of Molecular Sciences 22, no. 5 (February 28, 2021): 2433. http://dx.doi.org/10.3390/ijms22052433.
Full textZhang, Wenbiao, Jiacong Ye, Xinling Li, Yinghe Li, and Guokai Feng. "Integrin α6 targeted cancer imaging and therapy." Visualized Cancer Medicine 4 (2023): 4. http://dx.doi.org/10.1051/vcm/2022007.
Full textBode, Ann M., and Zigang Dong. "Molecular and cellular targets." Molecular Carcinogenesis 45, no. 6 (2006): 422–30. http://dx.doi.org/10.1002/mc.20222.
Full textChen, Buze, Xin Jin, Haihong Wang, Qingmei Zhou, Guilin Li, and Xiaoyuan Lu. "Network Pharmacology, Integrated Bioinformatics, and Molecular Docking Reveals the Anti-Ovarian Cancer Molecular Mechanisms of Cinnamon (Cinnamomum cassia (L.) J. Presl)." Natural Product Communications 17, no. 8 (August 2022): 1934578X2211191. http://dx.doi.org/10.1177/1934578x221119118.
Full textOng, Samantha Kah Ling, Muthu K. Shanmugam, Lu Fan, Sarah E. Fraser, Frank Arfuso, Kwang Seok Ahn, Gautam Sethi, and Anupam Bishayee. "Focus on Formononetin: Anticancer Potential and Molecular Targets." Cancers 11, no. 5 (May 1, 2019): 611. http://dx.doi.org/10.3390/cancers11050611.
Full textLim, W. M., S. Nalliah, F. F. L. Chung, K. K. Chan, and C. O. Leong. "Identification of New Molecular Targets for Treatment of Endometrial Cancers." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 203s. http://dx.doi.org/10.1200/jgo.18.82300.
Full textRouamba, Ablassé, Moussa Compaoré, and Martin Kiendrebeogo. "Molecular targets of honey bee’s products in cancer prevention and treatment." Journal of Herbmed Pharmacology 8, no. 4 (August 1, 2019): 261–68. http://dx.doi.org/10.15171/jhp.2019.38.
Full textFlaherty, Keith T. "New molecular targets in melanoma." Current Opinion in Oncology 16, no. 2 (March 2004): 150–54. http://dx.doi.org/10.1097/00001622-200403000-00012.
Full textHeaney, Anthony P., and Shlomo Melmed. "Molecular targets in pituitary tumours." Nature Reviews Cancer 4, no. 4 (April 2004): 285–95. http://dx.doi.org/10.1038/nrc1320.
Full textGupta, Shilpi, Prabhat Kumar, and Bhudev C. Das. "HPV: Molecular pathways and targets." Current Problems in Cancer 42, no. 2 (March 2018): 161–74. http://dx.doi.org/10.1016/j.currproblcancer.2018.03.003.
Full textNakhjavani, Maryam, Jennifer E. Hardingham, Helen M. Palethorpe, Yoko Tomita, Eric Smith, Tim J. Price, and Amanda R. Townsend. "Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer." Medicines 6, no. 1 (January 23, 2019): 17. http://dx.doi.org/10.3390/medicines6010017.
Full textLowe, Leroy, J. William LaValley, and Dean W. Felsher. "Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach." Cancer Drug Resistance 5 (2022): 917–25. http://dx.doi.org/10.20517/cdr.2022.40.
Full textKelleher, Fergal C., Andrew J. Colebatch, and Aparna Rao. "New Molecular Targets in Lung Adenocarcinoma." Oncology & Hematology Review (US) 09, no. 02 (2013): 122. http://dx.doi.org/10.17925/ohr.2013.09.2.122.
Full textPark, Woo-Chan, Lee Su Kim, Tae Hyun Kim, Byeong-Woo Park, Ho Yong Park, Byung Joo Song, Jae Bok Lee, Chang Wan Jeon, and Un-Jong Choi. "Molecular Targets for Treatment of Breast Cancer." Journal of Breast Cancer 12, no. 4 (2009): 229. http://dx.doi.org/10.4048/jbc.2009.12.4.229.
Full textPantano, Francesco, Giulia Ribelli, Michele Iuliani, Marco Fioramonti, Mark Leakos, Alice Zoccoli, Daniele Santini, Giovanni Muto, and Giuseppe Tonini. "New Molecular Targets in Metastatic Prostate Cancer." Journal of Cancer Therapy 07, no. 06 (2016): 388–401. http://dx.doi.org/10.4236/jct.2016.76042.
Full textEhlerding, E. B., C. G. England, D. G. McNeel, and W. Cai. "Molecular Imaging of Immunotherapy Targets in Cancer." Journal of Nuclear Medicine 57, no. 10 (July 28, 2016): 1487–92. http://dx.doi.org/10.2967/jnumed.116.177493.
Full textStolfi, Carmine, Roberto Pellegrini, Francesco Pallone, and Giovanni Monteleone. "Molecular Targets of Mesalazine in Colorectal Cancer." Current Cancer Therapy Reviews 4, no. 4 (November 1, 2008): 262–66. http://dx.doi.org/10.2174/157339408786413326.
Full textHumeniuk, Rita, Prasun Mishra, Joseph Bertino, and Debabrata Banerjee. "Molecular Targets for Epigenetic Therapy of Cancer." Current Pharmaceutical Biotechnology 10, no. 2 (February 1, 2009): 161–65. http://dx.doi.org/10.2174/138920109787315123.
Full textImyanitov, Eugene. "MOLECULAR TARGETS IN LUNG CANCER: CURRENT STATUS." Practical oncology 19, no. 2 (June 30, 2018): 93–105. http://dx.doi.org/10.31917/1902093.
Full textPalozza, Paola. "Carotenoids and Modulation of Cancer: Molecular Targets." Current Pharmacogenomics 2, no. 1 (March 1, 2004): 35–45. http://dx.doi.org/10.2174/1570160043476169.
Full textShtivelman, Emma, Tomasz M. Beer, and Christopher P. Evans. "Molecular pathways and targets in prostate cancer." Oncotarget 5, no. 17 (August 29, 2014): 7217–59. http://dx.doi.org/10.18632/oncotarget.2406.
Full textDawson, Nancy A. "New molecular targets in advanced prostate cancer." Expert Review of Anticancer Therapy 6, no. 7 (July 2006): 993–1002. http://dx.doi.org/10.1586/14737140.6.7.993.
Full textCindy D. Davis and John A. Milner. "Molecular Targets for Nutritional Preemption of Cancer." Current Cancer Drug Targets 7, no. 5 (August 1, 2007): 410–15. http://dx.doi.org/10.2174/156800907781386560.
Full textAlfonso, L., G. Ai, R. C. Spitale, and G. J. Bhat. "Molecular targets of aspirin and cancer prevention." British Journal of Cancer 111, no. 1 (May 29, 2014): 61–67. http://dx.doi.org/10.1038/bjc.2014.271.
Full textHodes, R. "Molecular targeting of cancer: Telomeres as targets." Proceedings of the National Academy of Sciences 98, no. 14 (July 3, 2001): 7649–51. http://dx.doi.org/10.1073/pnas.151267698.
Full textSCHALKEN, JACK A. "Validation of molecular targets in prostate cancer." BJU International 96, s2 (December 2005): 23–29. http://dx.doi.org/10.1111/j.1464-410x.2005.05943.x.
Full textGazdar, Adi F., Kuniharu Miyajima, Jyotsna Reddy, Ubaradka G. Sathyanarayana, Hisayuki Shigematsu, Makoto Suzuki, Takao Takahashi, and Narayan Shivapurkar. "Molecular Targets for Cancer Therapy and Prevention." Chest 125, no. 5 (May 2004): 97S—101S. http://dx.doi.org/10.1378/chest.125.5_suppl.97s-a.
Full textHong, Liu, Shujun Li, Yu Han, Jianjun Du, Hongwei Zhang, Jipeng Li, Qingchuan Zhao, Kaichun Wu, and Daiming Fan. "Angiogenesis-related molecular targets in esophageal cancer." Expert Opinion on Investigational Drugs 20, no. 5 (March 28, 2011): 637–44. http://dx.doi.org/10.1517/13543784.2011.571203.
Full text